Laurie Toich, Assistant Editor

Opdivo is approved for metastatic melanoma, non-small cell lung cancer, renal cell carcinoma, and classical Hodgkin lymphoma.

The FDA recalled “Side Head Regulator TT” tablets due to elevated levels of lead.

A normal level of HDL does not necessarily reduce the risk of mortality.

Gilenya may cause an increase in CD56+-expressing T cells, which can cause MS relapse.

Transcaval access could allow high-risk patients to receive surgical intervention for aortic valve stenosis.

Using data and bioinformatics could hold the key to numerous treatment options.

Top news of the day from across the healthcare landscape.

New therapeutic targets provide hope for targeted treatments for rheumatoid diseases.

JAK inhibitors may be more effective than older biologic drugs in certain patients.

Hospital rankings may be skewed by transfer rates and treatment volumes.

New data from studies of multiple drugs highlights Janssen’s commitment to rheumatic diseases.

Pfizer will highlight successes of Xeljanz at ACR/ARHP annual meeting.

A 2-year study will examine the effectiveness of advanced MRI to determine response to breast cancer treatment.

A recent review outlines the best treatment option to prevent bone loss associated with rheumatoid arthritis.

The cost of long-term care has caused some Medicare beneficiaries to spend their savings to be eligible for Medicaid services.

The companies plan to collaborate on clinical trials of a novel combination therapy for multiple myeloma.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Long-term oxygen treatment did not improve survival in patients with COPD with moderately low blood oxygen levels.

The Amplatzer Occluder device can reduce recurrent strokes in patients with a heart defect.

Opioid poisonings attributed to methadone in teenagers increased 950% from 1997 to 2012.

Amgen will present findings from clinical studies of both branded and investigational drugs.

Allergan plans to acquire Motus Therapeutics and relamorelin, an investigational drug to treat diabetic gastroparesis.

Accreditation provides value for specialty pharmacy patients and stakeholders.

Patients at high risk of early discontinuation of Betaferon should receive consistent care from physicians.

Patients with MS show damage to the pyramidal system had diminished posture control.

Quality measures for in-home healthcare should reflect the needs of the population being treated.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Virologically suppressed HIV-positive patients benefit from switching their treatment regimens to those involving Odefsey.